View study details on clinicaltrials.gov.
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
A Randomized PhaseII Study of Carboplatin and Pemetrexed w/ or w/o Selpercatinib in ParticipantsWith Non-Squamous RET Fusion-Positive Stage IV Non-Small Cell Lung Cancer andProgression of Disease on Prior RET Directed Therapy (Lung-MAP Sub-Study)
Investigator: Jiang Li, Ph.D., MPH